Literature DB >> 7121527

Ventricular defibrillation -- a comparative trial using 175-J and 320-J shocks.

W D Weaver, L A Cobb, M K Copass, A P Hallstrom.   

Abstract

We compared the effects of initial electrical shocks using 175 and 320 J (joules) in 249 patients with ventricular fibrillation. Survival was unrelated to the energy level used for defibrillation. Reversion to an organized rhythm occurred in a similar proportion of both treatment groups after one or two shocks. The rhythm identified after the first shock was related to outcome (the survival rate was 42 per cent in patients with supraventricular rhythm, 30 per cent in persistent ventricular fibrillation, 26 per cent in idioventricular rhythm, and 14 per cent in asystole; P less than 0.02). Fibrillation recurred in 68 per cent of patients who had been initially defibrillated to an organized rhythm. Repeated shocks at the higher energy level resulted in a higher incidence of atrioventricular block after defibrillation (24 per cent of patients receiving 320 J and 9 per cent of those receiving shocks of lower energy; P less than 0.005). Patients who survived required fewer shocks than patients who later died in the hospital (2.6 shocks as compared with 3.6; P less than 0.005). We conclude that initial defibrillatory shocks using 175 J are as safe and effective as shocks of nearly twice that energy level.

Entities:  

Mesh:

Year:  1982        PMID: 7121527     DOI: 10.1056/NEJM198210283071801

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  16 in total

1.  Ascorbic acid mitigates the myocardial injury after cardiac arrest and electrical shock.

Authors:  Min-Shan Tsai; Chien-Hua Huang; Chia-Ying Tsai; Huei-Wen Chen; Hsin-Chen Lee; Hsaio-Ju Cheng; Chiung-Yuan Hsu; Tzung-Dau Wang; Wei-Tien Chang; Wen-Jone Chen
Journal:  Intensive Care Med       Date:  2011-09-28       Impact factor: 17.440

2.  Regional cooling facilitates termination of spiral-wave reentry through unpinning of rotors in rabbit hearts.

Authors:  Masatoshi Yamazaki; Haruo Honjo; Takashi Ashihara; Masahide Harada; Ichiro Sakuma; Kazuo Nakazawa; Natalia Trayanova; Minoru Horie; Jérôme Kalifa; José Jalife; Kaichiro Kamiya; Itsuo Kodama
Journal:  Heart Rhythm       Date:  2011-08-10       Impact factor: 6.343

Review 3.  Recent advances and controversies in adult cardiopulmonary resuscitation.

Authors:  Wanis H Ibrahim
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

4.  Early out-of-hospital experience with an impedance-compensating low-energy biphasic waveform automatic external defibrillator.

Authors:  R D White
Journal:  J Interv Card Electrophysiol       Date:  1997-11       Impact factor: 1.900

5.  Determinants of successful transthoracic defibrillation and outcome in ventricular fibrillation.

Authors:  G W Dalzell; A A Adgey
Journal:  Br Heart J       Date:  1991-06

6.  Twenty years of prehospital coronary care.

Authors:  J S Geddes
Journal:  Br Heart J       Date:  1986-12

7.  Monitoring normal and aberrant electrocardiographic activity from an endotracheal tube: comparison of the surface, esophageal, and tracheal electrocardiograms.

Authors:  J K Hayes; J L Peters; K W Smith; C M Craven
Journal:  J Clin Monit       Date:  1994-03

8.  Incidence and outcomes of rearrest following out-of-hospital cardiac arrest.

Authors:  David D Salcido; Matthew L Sundermann; Allison C Koller; James J Menegazzi
Journal:  Resuscitation       Date:  2014-10-23       Impact factor: 5.262

9.  Relationship between canine transthoracic impedance and defibrillation threshold. Evidence for current-based defibrillation.

Authors:  B B Lerman; H R Halperin; J E Tsitlik; K Brin; C W Clark; O C Deale
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

10.  Prognostic importance of defibrillator shocks in patients with heart failure.

Authors:  Jeanne E Poole; George W Johnson; Anne S Hellkamp; Jill Anderson; David J Callans; Merritt H Raitt; Ramakota K Reddy; Francis E Marchlinski; Raymond Yee; Thomas Guarnieri; Mario Talajic; David J Wilber; Daniel P Fishbein; Douglas L Packer; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.